Clinical Trial Update: H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the immunogenicity of the H1N1 influenza vaccine in HIV-1 infected patients; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• H1N1 influenza vaccine (Influenza A/H1N1 vaccine)

Snippet

Sponsor: University of Pennsylvania | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2016-07-12